权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Gaps and Determinants in PrEP Uptake and Need: Understanding Disparities in PrEP Among Women in the United States

PrEP 采用和需求方面的差距和决定因素：了解美国女性 PrEP 方面的差异

基本信息

批准号：
10762821
负责人：
Brady W Bennett
金额：
$ 4.77万
依托单位：
EMORY UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-01 至 2025-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10762821
关键词：
AIDS prevention Affect African American Behavior Behavioral Black race Categories Characteristics Data Data Set Databases Diagnosis Disparate Disparity Eligibility Determination Epidemic Epidemiology Equation Equity Ethnic Origin Evaluable Disease Family Geography Goals Government Growth Guidelines HIV HIV Infections HIV diagnosis HIV risk Health Personnel Heterosexuals Hispanic Inequity Infection Knowledge Latinx population Logistic Regressions Methodology Methods Modeling Oral Pattern Performance Pharmacologic Substance Pharmacy facility Policies Public Health Race Records Research Risk Risk Factors Sexual Partners Socioeconomic Status Spatial Distribution Surveys Training United States United States Dept. of Health and Human Services Woman Work black women career comparative data quality health equity low socioeconomic status male men men who have sex with men pre-exposure prophylaxis sex sociodemographic factors spatiotemporal statistics uptake validation studies

项目摘要

ABSTRACT Women accounted for 18% of new HIV diagnoses in the United States in 2020 and yet only 7.4% of the pre- exposure prophylaxis (PrEP) users. Additionally, 71% of the women diagnosed with HIV in 2020 were Black/African American or Hispanic. PrEP has been shown to reduce incident HIV infection, providing a substantial public health opportunity to work towards the US Department of Health and Human Services announced the Ending the HIV Epidemic initiative. However, a substantial component of risk of HIV infection for women relates to the behaviors of their male sex partners, and these risks of partners may be unknown to women. Additionally, the completeness of data on race/ethnicity in key datasets used to document PrEP users in the US is limited leading to bias in our estimates. The proposed analysis will (1) determine the characteristics of women based on their partnerships that are indications for PrEP, particularly those indications unrecognized by women and their healthcare providers, 2) use multiple imputation to complete race/ethnicity data in current pharmaceutical use datasets to better understand the current racial/ethnic distribution of women PrEP users, and 3) analyze spatio-temporal patterns of PrEP uptake among women in the United States. Taken together, the goal of this proposal is to advance our understanding of among whom PrEP is needed, racial/ethnicity distributions among whom PrEP is currently being utilized, and where uptake is disparate considering risk factors for HIV infection.

摘要